A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Researchers indicate that switching to orforglipron offers an "effective approach" for sustaining weight loss, especially for those not wishing to remain on jabs. Experts also note the drug is "significantly cheaper to manufacture" than current options like Wegovy and Mounjaro. Orforglipron, a GLP-1 agonist, works by lowering blood sugar levels, slowing food digestion and reducing appetite. Experts also note the drug is ‘significantly cheaper to manufacture’ than current options like Wegovy and Mounjaro (James Manning/PA) However, instead of being injected, it is taken once-a-day as a tablet. The drug – made by Eli Lily – is not yet licensed in the UK, but was approved by the Food and Drug Administration in the US last month.…